S3200 ABP 710, a Biosimilar to Infliximab Reference Product: Supporting Extrapolation of Indications With a Focus on Crohn’s Disease
2020 ◽
Vol 115
(1)
◽
pp. S1678-S1679
Keyword(s):
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S121-S121
2019 ◽
Vol 114
(1)
◽
pp. S13-S14
Keyword(s):
1981 ◽
Vol 117
(10)
◽
pp. 674-675
◽
Keyword(s):